1Leung N. Treatment of chronic hepatitis B: case selection and duration of therapy. J Gastroenterol Hepatol,2002,17 : 409-414.
2Liao YF, Chen RN, Yeh C, et al. Acute exacerbation and hepatitis Bvirus clearance after emergence of YMDD motif mutation during lamivudine therapy. Hepatolngy, 1999,30 : 567-572.
3Albert DM, Thomas DS, Chaim SA, et al. Acute hepatic decompensation associated with emergence of lamivudine resistant hepatitis B virus.Hepatology, 2000,32 : 457 A.
4Tassopoulos NC, Volpes R, Pastore G, et al. Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive( precore mutant) chronic hepatitis B. Hepatology, 1999,29 : 889-896.
9Liaw YF,Leung NW,Chang TT,et al. Effects of extended Lamivudine therapy in asian paitnets with chronic hepatitis B. Gastroenterology,2000,119(1): 172-180
10Ono-Nita SK,Kato N,Shiratori Y,et al. YMDD motif in hepatitis B virus DNA polymerase influeces on replication and Lamivudine resistance: a study by in vitro full-length viral DNA transfection. Hepatology,1999,29(3): 939-945
